Company Description Date Funded Progress Notes
AntigenomYics, Inc.
Antigenome technology for Ab Target Identification 2019
Tellus Therapeutics, Inc.
small molecules derived from human breast milk for treatment of brain injuries 2019 Orphan Drug & Rare Pediatric Disease designations; $250K NCBC loan; $500K CTSI funding; $696 SBIR funding
Basking Biosciences Inc.
Antidote-controlled vWF inhibitor 2019 $2.2M SBIR funding; $5.4M financing
Lumedica Vision, Inc.
ophthalmic imaging (OCT) 2019 $1M NSF SBIR funding; $1M NIH SBIR funding; $900K 2020 revenues
surgical big data project 2017 $6.5M financing
OmniSono, Inc.
3D Ultrasound imaging 2018
Gateway Bio
polymer systems for diagnostics and drug delivery 2017
Higgs Boson, LLC
software app for supporting patients and their caregivers throughout their entire surgical journey, from planning to recovery and rehabilitation 2017 $870K financing; $250K NCBC loan
Topical treatment for pain 2017
Innovations 4 Surgery, LLC
Ultrasonic bone saw 2017
Eydis Bio, Inc.
A platform of tethered molecules that enable both detection and ablation of malignant tumors 2016
Mastezellen Bio, Inc.
Therapeutics for treatment of diseases and disorders with mast cell involvement 2016
InnaVasc Products for vascular access & hemodialysis 2015 $2M Financing; $2M Phase II NIH SBIR funding, $3M Phase IIB; NSF $800K SBIR funding; FDA-approved IDE
Upstream Therapeutics, Inc.
Therapeutics for treating inflammation and disorders involving immune activation 2015
Deep Blue Medical Advances, Inc.
Surgical mesh for hernia repair 2015 STTR Grant ($225K); CTSA Pilot Award ($100K); NC Biotechnology Center (NCBC) (i) Technology Enhancement Grant ($75K); ii) Loan ($250K); $1.5M financing; FDA 510K Clearance
Cellective Biotherapy Biotherapies for treating autoimmunity and oncology 2015 $2.5M Financing